Delivery Order SPE2DE24D0013-SPE2D625F4EEA
- Not listed
- The Defense Logistics Agency awarded a $40.8K delivery order (Contract 4569470191) to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for the supply of COVID-19/Flu/RSV testing solutions. This firm fixed-price delivery order, with an ultimate completion date of September 23, 2025, carries no set-aside designation and represents part of Cepheid's broader supply relationship with the Defense Department's medical supply chain operations. Cepheid specializes in...
- The U.S. Defense Logistics Agency, through its Medical Supply Chain division, awarded a $6,800 firm fixed-price delivery order to Cepheid Inc. for the supply of XPert Xpress COVID-19, Influenza, and RSV molecular diagnostic test kits. The delivery order, issued on September 3, 2025, with an ultimate completion date of September 10, 2025, represents a routine procurement under Cepheid's existing federal contract vehicles. The work will be performed at Cepheid's facility in Sunnyvale,...
- The Defense Department's Medical Supply Chain awarded Cepheid a $6.8K firm fixed-price delivery order on August 14, 2025, for the XpertXpress COVID-19, Flu, RSV, and molecular biology test kit. This delivery order represents a single procurement action under one of Cepheid's larger indefinite delivery vehicles with the Department of Veterans Affairs (VA), which provides ongoing access to the company's molecular diagnostic testing systems and reagents. The contract is set to complete by August...
- The Defense Logistics Agency Medical Supply Chain awarded a $10.2K firm fixed-price delivery order to Cepheid Inc. on July 22, 2025, for the XpertXpress COVID-19, Influenza, RSV, and Molecular Biology test kit. Cepheid, a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, will perform the work at its California facility. This delivery order carries no set-aside designation and represents a continuation of Cepheid's long-standing relationship supplying diagnostic...
- The U.S. Defense Department's Medical Supply Chain awarded Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, a firm fixed-price delivery order valued at $20,400 on August 11, 2025, with an ultimate completion date of August 18, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, involves diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV)—infectious diseases commonly detected through Cepheid's GeneXpert molecular...
- The U.S. Defense Logistics Agency awarded a $29,478.60 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, on August 6, 2025, with an ultimate completion date of August 13, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic testing solutions for COVID-19, influenza, and respiratory syncytial virus (RSV) detection. The contract carries no set-aside designation and represents a relatively modest...
- Cepheid, a molecular diagnostics manufacturer based in Sunnyvale, California, received a $6.8K delivery order from the Defense Logistics Agency's Medical Supply Chain division on July 22, 2025, for the KIT XPERT XPRESS COVID-19/FLU/RSV + Molecular Biology diagnostic kit. This firm fixed-price delivery order, with performance completion targeted for July 29, 2025, carries no set-aside designation and represents part of Cepheid's ongoing supply of molecular diagnostic testing solutions to...
- The U.S. Defense Department's Medical Supply Chain awarded a $6.8K firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, for a Kit Xpert Xpress COVID-19, Flu, RSV, plus Molecular Biology diagnostic product. The award was issued on July 29, 2025, with an ultimate completion date of August 1, 2025, and carries no set-aside designation. The delivery order will be performed in Sunnyvale, California, leveraging Cepheid's core...
- The U.S. Defense Department's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based molecular diagnostics manufacturer, on September 5, 2025, with completion targeted for September 19, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). This award carries no set-aside designation and represents a continuation of Cepheid's...
- The U.S. Department of Defense, through its Medical Supply Chain division, awarded a $20,400 firm fixed-price delivery order to Cepheid Inc. on July 10, 2025, with an ultimate completion date of July 17, 2025. The contract, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a Sunnyvale, California-based manufacturer specializing in advanced diagnostic systems, will perform the work at its...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F4EEADelivery Order
The Defense Logistics Agency awarded a $13.6K delivery order to Cepheid Inc. for the Xpert Xpress COVID-19/Flu/RSV molecular diagnostic kit on September 25, 2025. This firm fixed-price contract, with performance in Sunnyvale, California, represents a single delivery order with no set-aside designation. Cepheid, a leading manufacturer of molecular diagnostic solutions, supplies rapid point-of-care testing kits designed to detect multiple respiratory pathogens simultaneously, supporting the Defense Department's medical supply chain requirements for diagnostic capabilities across military and healthcare systems. This award builds on Cepheid's substantial existing federal presence in molecular diagnostics. The company maintains two significant Indefinite Delivery Vehicles with the Department of Veterans Affairs valued at over $35M combined, providing comprehensive PCR testing and diagnostic reagents for infectious disease detection. Cepheid's federal contract portfolio demonstrates consistent demand for its GeneXpert diagnostic systems and associated molecular testing solutions across defense and civilian healthcare agencies, reflecting the ongoing need for advanced diagnostic capabilities in federal medical supply chains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $13.6k | 9/25/25 |